98 related articles for article (PubMed ID: 19159823)
1. The pharmacodynamic effect of sirolimus: individual variation of cytokine mRNA expression profiles in human whole blood samples.
Müller-Steinhardt M; Wortmeier K; Fricke L; Ebel B; Härtel C
Immunobiology; 2009; 214(1):17-26. PubMed ID: 19159823
[TBL] [Abstract][Full Text] [Related]
2. Individual variability in cyclosporin A sensitivity: the assessment of functional measures on CD28-mediated costimulation of human whole blood T lymphocytes.
Härtel C; Hammers HJ; Schlenke P; Fricke L; Schumacher N; Kirchner H; Müller-Steinhardt M
J Interferon Cytokine Res; 2003 Feb; 23(2):91-9. PubMed ID: 12744774
[TBL] [Abstract][Full Text] [Related]
3. An assay for the determination of sirolimus levels in the lymphocyte of transplant patients.
Masri M; Rizk S; Barbari A; Stephan A; Kamel G; Rost M
Transplant Proc; 2007 May; 39(4):1204-6. PubMed ID: 17524933
[TBL] [Abstract][Full Text] [Related]
4. Sensitivity of whole-blood T lymphocytes in individual patients to tacrolimus (FK 506): impact of interleukin-2 mRNA expression as surrogate measure of immunosuppressive effect.
Härtel C; Schumacher N; Fricke L; Ebel B; Kirchner H; Müller-Steinhardt M
Clin Chem; 2004 Jan; 50(1):141-51. PubMed ID: 14709642
[TBL] [Abstract][Full Text] [Related]
5. Delayed cytokine mRNA expression kinetics after T-lymphocyte costimulation: a quantitative measure of the efficacy of cyclosporin A-based immunosuppression.
Härtel C; Fricke L; Schumacher N; Kirchner H; Müller-Steinhardt M
Clin Chem; 2002 Dec; 48(12):2225-31. PubMed ID: 12446480
[TBL] [Abstract][Full Text] [Related]
6. Pharmacodynamic effects of everolimus on anti-CD3 antibody-stimulated T-lymphocyte proliferation and interleukin-10 synthesis in stable kidney-transplant patients.
Böhler T; Waiser J; Lichter S; Schumann B; Neumayer HH; Kamar N; Budde K
Cytokine; 2008 Jun; 42(3):306-11. PubMed ID: 18440821
[TBL] [Abstract][Full Text] [Related]
7. Conversion to sirolimus-based maintenance immunosuppression using daclizumab bridge therapy in renal transplant recipients.
Sundberg AK; Rohr MS; Hartmann EL; Adams PL; Stratta RJ
Clin Transplant; 2004; 18 Suppl 12():61-6. PubMed ID: 15217410
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-21: an interleukin-2 dependent player in rejection processes.
Baan CC; Balk AH; Dijke IE; Korevaar SS; Peeters AM; de Kuiper RP; Klepper M; Zondervan PE; Maat LA; Weimar W
Transplantation; 2007 Jun; 83(11):1485-92. PubMed ID: 17565322
[TBL] [Abstract][Full Text] [Related]
9. Different profile of gene expression of cytokines in peripheral blood mononuclear cells of transplant recipients treated with m-TOR inhibitor and calcineurin inhibitor.
Niemczyk M; Zegarska J; Pawłowska M; Wyzgał J; Ciszek M; Paczek L
Transpl Immunol; 2009 Jan; 20(3):139-42. PubMed ID: 18834941
[TBL] [Abstract][Full Text] [Related]
10. The role and value of sirolimus administration in kidney and liver transplantation.
Mehrabi A; Fonouni H; Kashfi A; Schmied BM; Morath Ch; Sadeghi M; Schemmer P; Encke J; Sauer P; Zeier M; Weitz J; Büchler MW; Schmidt J
Clin Transplant; 2006; 20 Suppl 17():30-43. PubMed ID: 17100699
[TBL] [Abstract][Full Text] [Related]
11. Affects of immunosuppression on circulating dendritic cells: an adjunct to therapeutic drug monitoring after heart transplantation.
Barten MJ; Garbade J; Bittner HB; Fiedler M; Dhein S; Thiery J; Mohr FW; Gummert JF
Int Immunopharmacol; 2006 Dec; 6(13-14):2011-7. PubMed ID: 17161355
[TBL] [Abstract][Full Text] [Related]
12. The impact of interleukin-6 promoter -597/-572/-174genotype on interleukin-6 production after lipopolysaccharide stimulation.
Müller-Steinhardt M; Ebel B; Härtel C
Clin Exp Immunol; 2007 Feb; 147(2):339-45. PubMed ID: 17223976
[TBL] [Abstract][Full Text] [Related]
13. Synergistic effects of Isatis tinctoria L. and tacrolimus in the prevention of acute heart rejection in mice.
Wang Y; Qin Q; Chen J; Kuang X; Xia J; Xie B; Wang F; Liang H; Qi Z
Transpl Immunol; 2009 Dec; 22(1-2):5-11. PubMed ID: 19766187
[TBL] [Abstract][Full Text] [Related]
14. Conversion to sirolimus in renal transplant recipients: a single-center experience.
Yelken B; Caliskan Y; Ozkan O; Gorgulu N; Yazici H; Turkmen A; Sever MS
Artif Organs; 2010 Aug; 34(8):E230-7. PubMed ID: 20618227
[TBL] [Abstract][Full Text] [Related]
15. Cyclosporine and sirolimus pharmacokinetics and drug-to-drug interactions in kidney transplant recipients.
Felipe CR; Park SI; Pinheiro-Machado PG; Garcia R; Casarini DE; Moreira S; Tedesco-Silva H; Medina-Pestana JO
Fundam Clin Pharmacol; 2009 Oct; 23(5):625-31. PubMed ID: 19656203
[TBL] [Abstract][Full Text] [Related]
16. Increased intragraft IL-15 mRNA expression after liver transplantation.
Baan CC; Niesters HG; Metselaar HJ; Mol WM; Loonen EH; Zondervan PE; Tilanus HW; IJzermans JM; Schalm SW; Weimar W
Clin Transplant; 1998 Jun; 12(3):212-8. PubMed ID: 9642512
[TBL] [Abstract][Full Text] [Related]
17. Early sirolimus therapy in renal transplant recipients at high risk: is it justified?
Halim MA; Al-Otaibi T; Johny KV; Hamid MH; Al-Waheeb S; Hasaneen H; Awadain WH; Nawas KM; El-Sayed A; Said T; Nair MP; Nampoory MR
Transplant Proc; 2009 Sep; 41(7):2784-8. PubMed ID: 19765435
[TBL] [Abstract][Full Text] [Related]
18. The intragraft gene activation of markers reflecting T-cell-activation and -cytotoxicity analyzed by quantitative RT-PCR in renal transplantation.
Strehlau J; Pavlakis M; Lipman M; Maslinski W; Shapiro M; Strom TB
Clin Nephrol; 1996 Jul; 46(1):30-3. PubMed ID: 8832147
[TBL] [Abstract][Full Text] [Related]
19. Comparative evaluation of 'TaqMan' RT-PCR and RT-PCR ELISA for immunological monitoring of renal transplant recipients.
Gibbs PJ; Tan LC; Sadek SA; Howell WM
Transpl Immunol; 2003; 11(1):65-72. PubMed ID: 12727477
[TBL] [Abstract][Full Text] [Related]
20. Role of FK778 alone or in combination with tacrolimus or mTOR inhibitors as an immunomodulator of immunofunctions: in vitro evaluation of T cell proliferation and the expression of lymphocyte surface antigens.
Millán O; Jiménez O; Fortuna V; Barceló JJ; Brunet M
Int J Immunopathol Pharmacol; 2006; 19(2):317-30. PubMed ID: 16831299
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
